KR100392277B1 - Alismatis Rhizoma tea of granule type and process for prepatration therof - Google Patents

Alismatis Rhizoma tea of granule type and process for prepatration therof Download PDF

Info

Publication number
KR100392277B1
KR100392277B1 KR10-2000-0078054A KR20000078054A KR100392277B1 KR 100392277 B1 KR100392277 B1 KR 100392277B1 KR 20000078054 A KR20000078054 A KR 20000078054A KR 100392277 B1 KR100392277 B1 KR 100392277B1
Authority
KR
South Korea
Prior art keywords
extract
taxa
cells
tea
taxi
Prior art date
Application number
KR10-2000-0078054A
Other languages
Korean (ko)
Other versions
KR20020048781A (en
Inventor
서권일
조영숙
박정로
이성태
이용수
박석규
Original Assignee
순천시
조영숙
박정로
서권일
이성태
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 순천시, 조영숙, 박정로, 서권일, 이성태 filed Critical 순천시
Priority to KR10-2000-0078054A priority Critical patent/KR100392277B1/en
Publication of KR20020048781A publication Critical patent/KR20020048781A/en
Application granted granted Critical
Publication of KR100392277B1 publication Critical patent/KR100392277B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/30Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
    • A23F3/32Agglomerating, flaking or tabletting or granulating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby
    • A23F3/14Tea preparations, e.g. using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/214Tea

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 택사과립차 및 그 제조방법에 관한 것으로 택사 추출물의 항균활성, 항산화효과 및 면역활성을 확인하고, 택사 엑기스를 과립형 차로 제조함으로써 음용이 간편하고 택사의 고유한 조맛과 단맛이 조화를 이루는 택사과립차를 제공하는 뛰어난 효과가 있다.The present invention relates to a granule tea and a method for manufacturing the same, confirming the antimicrobial activity, antioxidant effect and immunological activity of the extract of the tax extract, and by preparing the extract as a granular tea extract is easy to drink and harmonizes the unique taste and sweetness of the taxi There is an excellent effect of providing a coarse grain tea.

Description

택사과립차 및 그 제조방법{Alismatis Rhizoma tea of granule type and process for prepatration therof}Taxi granulated tea and its manufacturing method {Alismatis Rhizoma tea of granule type and process for prepatration therof}

본 발명은 택사과립차 및 그 제조방법에 관한 것이다. 더욱 상세하게는, 본 발명은 항균활성, 항산화 효과 및 면역활성이 뛰어난 택사 엑기스를 부재료와 함께 혼합하고 제립, 건조, 사별 및 포장하여 제조한 택사과립차 및 그 제조방법에 관한 것이다.The present invention relates to a granulated granular tea and a manufacturing method thereof. More specifically, the present invention relates to a tack granulated tea produced by mixing tax extract, which is excellent in antimicrobial activity, antioxidant effect and immune activity, with subsidiary materials, and granulated, dried, separated and packaged.

택사과(澤瀉科;Alismataceae)식물인 택사(Alismatis Rhizoma)는 단자엽 식물중 진화하는 과정에서 분화된 잔존군으로 세계적으로 약 13속 90여종이 분포되어 있는데, 중국의 복건, 강서 사천, 귀천 및 운남지방에서도 많이 생산되고 있으며, 우리나라의 경우에는 그 생산량의 50% 이상을 차지하고 있는 전남 순천 지방을 비롯하여 전남 무안, 구례 및 경북 상주 지역에서 생산되고 있으며, 생약으로 쓰이는 택사는 질경이 택사(Alisma plantago-aquatica L. var. orientaleSamuels)가 주로 재배 생산된다. 택사의 함유성분은 전분 25%, 단백질 7%, 정유의 furfural, resin, 무기염과 triterpenoid계의 alisol A, B, C와 그 아세테이트(acetate) 및 당류로 알려져 있다. 이와 같은 택사는 예로부터 수분을 제거하고 오장을 도우며 기력을 튼튼히 하는 약재로 알려져 있으며, 칼륨(K) 많이 함유되어 있어 택사를 복용하게되면 뇨중의 칼륨(K)의 배출이 현저히 증가된다. 또한 택사는 혈중 콜레스테롤을 감소시키고, 혈압 및 혈중의 당을 낮추는 작용이 있고 사염화 탄소로 유발된 간독성에 유효한 보간작용이 있음이 보고된 바 있다. 또한 최근에는 택사분말이 무좀에도포약으로 쓰이고 있어 택사에는 다양한 생리활성물질이 존재하는 것으로 생각된다. 그러나 택사의 생리활성에 대한 실제적인 연구결과는 매우 부족하며 이를 이용한 건강식품에 대한 개발도 미흡한 실정이다. Alismatis Rhizoma , an Alismataceae plant, is a remnant group differentiated during the evolution of monocotyledonous plants, with about 13 genera and 90 species distributed worldwide. Fujian, Jiangxi, Sichuan, Guitian and It is also produced in Yunnan province, and in Korea, it is produced in the Jeonnam Suncheon region, which accounts for more than 50% of its production, in Muan, Gurye, and Sangju, Gyeongsangbuk-do, and the taxa used as a herbal medicine is Alisma plantago- aquatica L. var. orientale Samuels) is mainly grown and produced. The constituents of taxa are known as 25% starch, 7% protein, furfural, resin, essential salts, alisol A, B, C, and acetates and acetates of triterpenoids. Such taxa is known as a medicine that removes moisture, helps the intestine, and strengthens energy. It is contained a lot of potassium (K), and when the taxi is taken, potassium (K) in the urine is significantly increased. Taxa has also been reported to reduce blood cholesterol, lower blood pressure and blood sugar, and have an effective interpolation effect on hepatotoxicity induced by carbon tetrachloride. In addition, recently, the tactile powder has been used as a medicine for athlete's foot, so it is thought that various physiologically active substances are present in the tactical taxi. However, the actual research results on physiological activity of taxis are very insufficient and the development of health foods using them is insufficient.

본 발명자들은 상기와 같은 점을 착안하여 순천지역에서 생산되는 택사의 항균, 항산화 활성 및 면역반응 조절작용에 미치는 영향 등과 같은 생리활성을 규명하고 택사를 과립형차로 제조함으로써 본 발명을 완성하였다.The present inventors have completed the present invention by identifying the physiological activity such as the effects on the antibacterial, antioxidant activity and immune response control action of taxis produced in the Suncheon area by focusing on the above points and preparing the taxis as granular tea.

따라서, 본 발명의 목적은 택사과립차를 제공하는 것이다. 본 발명의 다른 목적은 택사과립차의 제조방법을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a coarse grain granular difference. Another object of the present invention is to provide a method for producing granulated granular tea.

도 1은 본 발명 택사추출물의 항균활성 측정을위해 시험균주에 택사 물추출물을 첨가한후 생성된 생육저해환을 나타내는 평판배지의 사진도이다.Figure 1 is a photograph of a plate medium showing the growth inhibition ring produced after the addition of the tax water extract to the test strain to determine the antimicrobial activity of the tax extract of the present invention.

도 2a는 본 발명 택사추출물의 바실러스 서브틸러스(B. subtilis)균주의 성장 억제효과를 나타낸 그래프이다.Figure 2a is a graph showing the growth inhibitory effect of the Bacillus subtilis strain of the present invention tack extract.

도 2b는 본 발명 택사추출물의 슈도모나스 아에리그노사(Pseudomonas aerignosa) 균주의 성장 억제효과를 나타낸 그래프이다.Figure 2b is a graph showing the growth inhibitory effect of Pseudomonas aerignosa strain of the present taxa extract.

도 2c는 본 발명 택사추출물의 대장균(E.coli) 균주의 성장 억제효과를 나타낸 그래프이다.Figure 2c is a graph showing the growth inhibitory effect of the E. coli strain E. coli extract of the present invention.

도 2d는 본 발명 택사추출물의 살모넬라 티피무리움(Salmonella typhymuriu- Figure 2d is Salmonella typhymuriu of the present invention taxa extract ( Salmonella typhymuriu-

m)균주의 성장 억제 효과를 나타낸 그래프이다. m ) It is a graph showing the growth inhibitory effect of the strain.

도 2e는 본 발명 택사추출물의 비브리오 파라하모리티커스(Vibrio parahaemoliticus) 균주의 성장 억제효과를 나타낸 그래프이다.Figure 2e is a graph showing the growth inhibitory effect of the Vibrio parahaemoliticus strain of the present taxa extract.

도 3은 택사추출물 처리에 따른 살모넬라 티피무리움(Salmonella typhymuriu Figure 3 is Salmonella typhymuriu according to the process of extracting talc

m)의 전자현미경 사진도이다. m ) electron micrograph.

도 4는 50℃에서 7일 동안 리놀레산 자동산화 과정중 택사추출물(100㎕) 첨가에 따른 과산화물가의 변화를 나타낸 그래프이다.Figure 4 is a graph showing the change in peroxide value according to the addition of the tack extract (100 μl) during linoleic acid automatic oxidation for 7 days at 50 ℃.

도 5는 50℃에서 7일 동안 리놀레산의 자동산화 과정중 택사추출물을 농도별 첨가에 따른 과산화물가의 변화를 나타낸 그래프이다.Figure 5 is a graph showing the change in peroxide value according to the concentration of the tacrus extract during the automatic oxidation of linoleic acid for 7 days at 50 ℃.

도 6은 본 발명 택사추출물을 쥐간에 처리시 TBA가의 변화를 나타낸 그래프이다.Figure 6 is a graph showing the change in TBA value when the present invention is treated with a rat extract.

도 7a는 본 발명 택사추출물을 비장세포에 처리시 비장세포의 증식에 미치는 영향을 나타낸 그래프이다.Figure 7a is a graph showing the effect on the proliferation of splenocytes when the present invention is treated to splenocytes.

도 7b는 본 발명 택사추출물을 B세포에 처리시 B세포의 증식에 미치는 영향을 나타낸 그래프이다.Figure 7b is a graph showing the effect on the proliferation of B cells when the present invention is treated to B cell tack extract.

도 8a는 본 발명 택사추출물이 동종항원에 대해 반응하는 T세포 증식에 미치는 영향을 나타낸 그래프이다.Figure 8a is a graph showing the effect of the present invention taxa extract on T cell proliferation in response to homologous antigen.

도 8b는 본 발명 택사추출물이 동종항원에 대해 반응하는 T세포의 저해도를 나타낸 그래프이다.Figure 8b is a graph showing the degree of inhibition of T cells in response to the tax extract of the present invention to homologous antigens.

도 9는 본 발명 택사추출물이 동종항원에 대해 반응하는 T세포의 세포독성에 미치는 영향을 나타낸 그래프이다.Figure 9 is a graph showing the effect of the present invention taxa extract on the cytotoxicity of T cells in response to homologous antigen.

도 10은 본 발명에 의한 택사과립차 제품의 사진도이다.10 is a photographic representation of a granulated granular tea product according to the present invention.

도 11은 본 발명의 바람직한 제조방법의 실시예를 공정별로 도시한 개략도이다.11 is a schematic diagram showing an embodiment of a preferred manufacturing method of the present invention step by step.

본 발명의 상기 목적은 택사 추출물을 제조하여 식중독 및 병원성 미생물에 대한 항균활성, 리놀레산과 간지질에 대한 항산화 효과 및 면역활성을 확인한 뒤 택사 추출물 엑기스를 제조하여 부재료와 혼합한 뒤 제립, 건조, 사별 및 포장 공정을 통하여 택사과립차를 제조함으로써 달성하였다.The object of the present invention is to prepare a taxa extract to determine the antimicrobial activity, food antioxidants and antimicrobial activity against linoleic acid and hepatic lipids for food poisoning and pathogenic microorganisms, and then to prepare a taxa extract extract and mixed with the subsidiary material, granulation, drying, bereavement And by preparing a coarse granular tea through a packaging process.

이하, 본 발명의 구성을 설명한다 .Hereinafter, the configuration of the present invention will be described.

본 발명은 택사의 항균, 항산화 및 면역활성을 조사하기 위하여 메탄올, 에탄올 및 물을 사용하여 택사 추출물을 제조하는 단계; 상기 택사추출물의 항균 활성을 조사하기 위하여 식중독 및 병원성 미생물에 대한 항균활성을 측정하고, 택사추출물의 처리에 따른 미생물의 형태변화를 조사하는 단계; 택사추출물의 항산화효과를 조사하기 위하여 리놀레산에 대한in vitro항산화 효과 및 간 지질과산화 억제 기능에 대하여 조사하는 단계; 택사 추출물의 면역세포 증식효과, 대식세포주의 일산화질소 생산에 미치는 영향, 동종항원에 대한 증식반응, 동종항원에 의한 T세포 사이토카인 분비량의 억제 및 동종항원에 대한 T세포의 살세포 작용 억제효과를 조사하는 단계; 상기 단계에서 항균효과, 항산화효과 및 면역활성 효과가 있는 것으로 확인된 택사에 70% 에탄올을 사용하여 택사 알콜 엑기스를 제조하는 단계; 택사 과립차 제조시 부원료로 첨가되는 유당, 포도당 및 비타민 C를 칭량하고 혼합하여 분쇄하는 단계; 상기 부원료에 택사 알콜 엑기스를 첨가하고 혼합한 뒤 역회전 과립기를 사용하여 제립하는 단계; 상기 단계에서 제조한 택사 추출물 과립을 60℃에서 5시간동안 건조한후 포장하여 제품화하는 단계로 구성된다The present invention comprises the steps of preparing a taxi extract using methanol, ethanol and water to investigate the antibacterial, antioxidant and immune activity of the taxi; Measuring antimicrobial activity against food poisoning and pathogenic microorganisms to investigate the antimicrobial activity of the taxa extract, and examining the morphological changes of the microorganisms according to the treatment of the taxa extract; Irradiating with respect to the in vitro antioxidant activity and lipid peroxidation inhibiting liver functions for the linoleic acid in order to examine the antioxidant activity of the extract Alismataceae; Effects of Taxa Extract on Immune Cell Proliferation, Effects of Macrophage Cells on Nitric Oxide Production, Proliferative Response to Homologous Antigens, Inhibition of T Cell Cytokine Secretion by Homologous Antigens, and T Cell Killer Action on Homologous Antigens Investigating; Preparing a taxa alcohol extract using 70% ethanol in the taxi, which has been identified as having antimicrobial, antioxidant and immune activity effects in the step; Weighing, mixing and pulverizing lactose, glucose and vitamin C, which are added as an auxiliary ingredient in the preparation of the taxi granule tea; Adding a taxane alcohol extract to the secondary raw material, mixing the granules, and then granulating the granules using a reverse-rotating granulator; Taxi extract granules prepared in the above step consists of drying at 60 ℃ for 5 hours and packaging and commercialized

본 발명 택사(Alismatis Rhizoma)는 1998년 전남 순천에서 수확한 것을 구입하여 사용하였다. 항균 시험용으로 사용한 균주Bacillus subtilis,Pseudomonas aeruginosa,Escherichia coli,Salmonella typhimurium,Escherichia coliO-157 및Vibrio parahaemolyticus는 한국 종균협회에서 분양 받아 사용하였다. 각종 미생물의 배양에 사용된 배지는 영양 배지(nutrient broth, agar)를 사용하였으며,Vibrio parahaemoliticus는 3% NaCl이 첨가된 배지를 사용하였다. Alismatis Rhizoma of the present invention purchased and used harvested in Suncheon, Jeonnam in 1998. The strains Bacillus subtilis , Pseudomonas aeruginosa , Escherichia coli , Salmonella typhimurium , Escherichia coli O-157 and Vibrio parahaemolyticus were used for antimicrobial testing. Nutrient broth (agar) was used for the culture of various microorganisms, and 3% NaCl was added for Vibrio parahaemoliticus .

택사의 면역활성 측정을 조사하기 위해 사용한 생쥐(BALB/c, C57BL/6)는, 대한실험동물센터(충북 음성군)에서 구입한 후 생후 8∼12주된 암컷을 사용하였으며, 실험 전까지 고형사료와 1차 증류수를 공급하면서 사육하였다. RPMI 1640배지, 안티바이오틱 안티마이코틱은 Gibco BRL(Grand Island, NY, USA)제품을 사용하였으며, FCS(fertal calf serum)은 PAA제품을 사용하였다. LPS와 2-ME(2-mercaptoehtanMice (BALB / c, C57BL / 6) used to investigate the immune activity of taxa were purchased from the Korea Experimental Animal Center (negative group Chungbuk), and 8-12 weeks old females were used. It was bred while supplying tea distilled water. RPMI 1640 medium, antibiotic antimicrobial was used Gibco BRL (Grand Island, NY, USA) products, FCS (fertal calf serum) was used PAA products. LPS and 2-ME (2-mercaptoehtan

ol), NaHCO3, N-1-나프틸-에틸렌-디아민(N-1-naphthyl-ethylen-diamine)과 썰파닐아마이드(Sufanilamide)는 Sigma사 제품을 사용하였다. 또한 세포독성 측정(Cytotoxicity assay)에 사용된 시약(Cyto Tox 96Non-radioactive Cytotoxicity Assay)과 세포증식 측정에 사용된 시약(Cell titer96Aqueous One solution cell proliferation Assay)은 Promega사 제품을 사용하였고, 사이토카인(cytokine)측정에 필요한 항체는 Pharmingen사의 제품을 사용하였다. B 세포 분리에 사용된 Sephadex G-10도 Pharmingen사의 제품을 사용하였다. 세포배양을 위한 세포주로는 생쥐 단핵/대식세포 계열의 세포주인 RAW264.7을 한국세포주은행(서울대학교 의과대학 암연구소)에서 구입하였다. 상기 세포배양을 위한 배지는 RPMI 1640배지에 NaHCO32g/L와 페니실린(penicillin) 100unit/ml, 스트렙토마이신 100mg/ml를 첨가하여 사용하였다.ol), NaHCO 3, N-1-naphthyl-ethylen-diamine and sulfanamide were used by Sigma. In addition, the reagents used in the cytotoxicity assay (Cyto Tox 96). Non-radioactive Cytotoxicity Assay and Reagents Used to Measure Cell Proliferation (Cell titer96) Aqueous One Solution Cell Proliferation Assay was used for Promega, and the antibodies required for cytokine measurement were used for Pharmingen. Sephadex G-10 used for B cell separation was also used by Pharmingen. As a cell line for cell culture, RAW264.7, a mouse mononuclear / macrophage cell line, was purchased from Korea Cell Line Bank (Seoul National University College of Medicine). Medium for the cell culture was used by adding NaHCO 3 2g / L, penicillin 100unit / ml, streptomycin 100mg / ml to RPMI 1640 medium.

택사 과립차 제조시 택사 추출물과 부재료의 배합비율의 결정은 혼합적성, 역회전과립기 사출적성, 관능평가등을 통하여 최종 적정 농도를 결정하였다. 시제품으로 생산된 택사 과립차는 택사의 고유한 조맛과 단맛의 조화를 이루며 택사 함량은 1.28g/3g이며 냉수에 5분이내에 용해되는 특징이 있다. 상기 택사 과립차는 온수 또는 냉수에 감미료와 함께 용해시켜 음용할 수 있다.Determination of the blending ratio of the taxi extract and the subsidiary materials in the preparation of the taxi granule tea was determined by the final suitability concentration through the mixing suitability, the anti-rotation granule injection suitability, sensory evaluation. Produced as a prototype, taxi granule tea combines the original taste and sweet taste of taxi, and the content of taxi is 1.28g / 3g and it is dissolved in cold water within 5 minutes. The taxi granule tea may be dissolved with sweetener in hot or cold water for drinking.

이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만,본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.

실시예 1: 택사 추출물 제조Example 1 Taxa Extract Preparation

항균활성 및 항산화능을 측정하기 위하여 사용한 택사(Alismatis Rhizoma) 추출물은 메탄올, 에탄올 및 물과 같은 용매를 사용하여 택사 100g당 1500ml의 비율로 용매를 첨가하고 환류냉각기를 이용하여 메탄올과 에탄올은 80℃, 물은 100℃에서 2시간 추출한후 택사 g 당 0.5ml가 되도록 농축하여 제조하였다. Alismatis Rhizoma extract used to measure antimicrobial activity and antioxidant activity was added at a rate of 1500 ml per 100 g of taxa using solvents such as methanol, ethanol and water, and methanol and ethanol at 80 ° C using a reflux condenser. , Water was prepared by extracting at 100 ℃ for 2 hours and concentrated to 0.5ml per g of taxi.

실험예 1: 택사 추출물의 항균효과 조사Experimental Example 1: Investigation of antimicrobial effect of taxa extract

택사 추출물의 항균효과를 조사하기 위하여 택사 추출물을 사용하여 항균력, 미생물 생육도에 미치는 영향, 미생물의 형태변화에 미치는 영향을 조사하였다.In order to investigate the antimicrobial effect of taxa extracts, the effects of antimicrobial activity, microbial growth, and microbial morphology were investigated.

항균력의 측정은 Farag의 방법을 변형하였다. 즉, agar 1.5%가 함유되어 있는 생육배지를 페트리 디쉬(petri dish)의 밑면에 얇게 펴고 그위에 다시 0.6%의 agar가 함유된 생육배지를 부어 2중의 평판 배지를 만든 후 각 균주를 평판배지에 도말하였다. 상기 균주가 도말된 평판배지에 택사추출물을 일정량 가한 직경 0.8cm의 여지 디스크(disc)를 올려놓고 36℃에서 24시간 배양한 뒤, 생성되는 생육저해환을 측정하여 항균력을 조사하였다.The measurement of antimicrobial activity modified Farag's method. That is, the growth medium containing 1.5% of agar is thinly spread on the bottom of a petri dish, and the growth medium containing 0.6% of agar is poured on it to make a double flat medium, and then each strain is placed on the flat medium. Smeared. The strain was placed on a plate medium coated with a certain amount of the tackifier extract 0.8cm in diameter filter disk (disc) and incubated for 24 hours at 36 ℃, the resulting growth inhibition was measured to investigate the antibacterial activity.

미생물의 생육도 측정은 액체배지 희석법을 사용하였다. 시험관에 5ml의 생육배지를 넣고 대수기 중기까지 배양된 균체 배양액 1%를 접종한 후 택사 추출물 함량을 배지 5ml당 30∼200㎕가 되도록 첨가하고 각 균주의 최적 온도에서 배양하면서 경시적으로 미생물의 생육정도를 분광광도계(spectrophotometer)를 사용하여 660nm에서 흡광도를 측정하였다.Microbial growth was measured using the liquid medium dilution method. Inoculate 5 ml of growth medium into the test tube and inoculate 1% of the cell culture cultured up to the middle of the logarithmic season, and then add tac extract extract to 30 to 200 µl per 5 ml of medium and incubate at optimum temperature of each strain. The extent of growth was measured by absorbance at 660nm using a spectrophotometer.

택사(Alismatis Rhizoma) 추출물에 의한 미생물의 형태변화 조사는 식품부패미생물에 택사 추출물을 처리한 후 전자현미경으로 그 형태 변화를 관찰하였다. 부패미생물로Salmonella typhimurium을 배지에 48시간 배양한 다음 배양 균주 일부에 택사 추출물을 배지 ml당 100㎕로 첨가하고 3시간 방치한 뒤 이를 원심분리하여 균체를 분리한 후 0.05M 인산 완충액(phosphate buffer)으로 희석하고 0.45㎕ membrane filter에 균체를 고정하였다. 이를 5% 글루타알데하이드(glutaaldehyde) 용액에 하룻밤 담구어 멸균수로 세척한 뒤 30∼100%의 에탄올에 차례로 담구어 탈수하고, 이소아밀아세테이트(isoamylacetate)에 약 30분간 담구어 건조시킨 후 전자현미경 촬영시료를 조제하여 관찰하였다.The morphological changes of microorganisms by Alismatis Rhizoma extracts were examined by electron microscopy after treatment with food extracts. Incubate Salmonella typhimurium as a decay microorganism in a culture medium for 48 hours, add 100 microliters of taxa extract per ml of culture strain to the culture strain, leave for 3 hours, and centrifuge to isolate the cells. 0.05M phosphate buffer The cells were diluted with and fixed to 0.45 μl membrane filter. Soak overnight in 5% glutaaldehyde (glutaaldehyde) solution, wash with sterile water, and then immerse in 30 ~ 100% ethanol one by one in order to dehydrate, immerse in isoamylacetate for about 30 minutes to dry and electron microscope The photographing sample was prepared and observed.

실험결과, 택사 추출물의 항균 활성은 도 1과 표1에 나타낸 바와 같이, 물추출물이 메탄올 및 에탄올 추출물보다 항균활성이 강하게 나타났다. 또한Escherichia coliO-157균주를 제외한 모든 시험균주에 대하여 항균활성이 강하게 나타났으며 각 시험균주에 대한 택사 추출물의 투명환(clear zone)은Vibrio parahaemolyticus, Bacillus subtilis, Salmonella typhimurium, Pseudomonas aeruginosa 및 Escherichia coli에 대하여 각각 18.0, 16.0, 16.0, 13.0, 11.5mm였으며 특히,Vibrio parahaemolyticus균주에 대해서 항균활성이 가장 강하게 나타났다.Experimental results, as shown in Figure 1 and Table 1, the antimicrobial activity of the taxa extract, water extract showed stronger antimicrobial activity than methanol and ethanol extract. Also had antimicrobial activity appeared strongly to all tested strains except for Escherichia coli O-157 strain clear zone (clear zone) of Alismataceae extract of each test strain Vibrio parahaemolyticus, Bacillus subtilis, Salmonella typhimurium, Pseudomonas aeruginosa and Escherichia coli Were 18.0, 16.0, 16.0, 13.0, and 11.5mm, respectively. In particular, the antimicrobial activity of Vibrio parahaemolyticus was the strongest.

택사 추출물의 항균활성Antimicrobial Activity of Taxa Extracts 균주Strain 메탄올 추출물Methanol extract 에탄올 추출물Ethanol extract 물 추출물Water extract Bacillus subtilisBacillus subtilis 14.014.0 13.513.5 16.016.0 Pseudomonas aerignosaPseudomonas aerignosa 14.014.0 14.014.0 13.013.0 E.coliE.coli 11.011.0 11.011.0 11.511.5 Salmonella typhymuriumSalmonella typhymurium 14.014.0 13.513.5 16.016.0 E.coliO-157 E.coli O-157 8.08.0 8.08.0 8.08.0 Vibrio parahaemolyticuaVibrio parahaemolyticua 16.016.0 16.516.5 18.018.0 〔주〕단위 :mm(Note) Unit: mm

택사(Alismatis Rhizoma) 추출물이 미생물의 증식에 미치는 영향을 조사한 결과, 도 2a, 2b, 2c, 2d, 2e에 나타낸바와 같이 택사추출물을 배지 5ml당 30㎕만 첨가하여도 균의 성장이 억제되었으며 150㎕ 첨가시는 거의 모든균에서 대조구에 비하여 50% 이상 균의 성장이 억제되었으며, 200㎕ 첨가시는 균의 성장이 거의 억제되었다.As a result of investigating the effect of Alismatis Rhizoma extract on the growth of microorganisms, as shown in Figures 2a, 2b, 2c, 2d, 2e, the growth of the bacteria was inhibited even by adding only 30 μl of the extract per 5ml medium. In addition, the growth of the bacteria was inhibited by 50% or more in almost all bacteria compared to the control.

택사 추출물 처리에 따른 미생물의 형태 변화를 조사한 결과, 도 3에 나타낸 바와 같이Salmonerlla typhimurium에 택사 물추출물을 처리한 후 대조구와 비교시 균체의 표층구조가 허물어지는 심한 형태적 변화를 나타내었다. 서 등(서권일,이상원, 양기호 :한국농산물저장유통학회(1999), 6(1))은E.coliO-157에 산수유 물추출물을 처리한후 전자현미경으로 관찰한 결과 대조구와 비교하여 산수유 물추출물을 처리한 균체에서 세포막 기능이 파괴되어 세포내용물이 균체 외부로 유출되어 균체의 생육이 억제되는 현상을 나타내었다고 보고하였고, 서 등은 대장균에 겨자 물추출물을 처리하였을 때 균체 표면이 수축되고 표층구조가 심하게 허물어졌다고 보고하였는데, 본 결과의 이와 같은 현상들도 상기의 연구보고와 비교하여 볼 때 택사 물추출물에 의한 미생물의 세포벽 및 세포막의 기능이 파괴되어 용균이나 균체성분의 노출로 인한 결과라고 생각된다.As a result of investigating the morphological changes of the microorganisms according to the extract of the taxa extract, as shown in FIG. 3, after treating the taxa water extract with Salmonerlla typhimurium , the surface structure of the cells was severely compared with the control group. Seo et al. (Seo Kwon Il, Sang Won Lee, Ki Ho Ho: Korean Agricultural Products Conservation & Distribution Association (1999), 6 (1)), treated with cornus water extract in E. coli O-157 and observed by electron microscopy. It was reported that the cell membrane function was disrupted in the cells treated with the extract and the contents of the cells were leaked to the outside of the cells, thereby inhibiting the growth of the cells. It was reported that the structure was severely collapsed.These phenomena are also the result of the exposure of lysates or cell components due to the destruction of the cell wall and cell membrane of microorganisms by taxi water extract. I think.

실험예 2: 택사 추출물의 항산화 효과 조사Experimental Example 2: Investigation of Antioxidant Effect of Taxa Extract

택사 추출물(Alismatis Rhizoma)의 리놀레산(linoleic acid)에 대한in vitro항산화 및 간 지질과산화 억제 기능에 대하여 조사하였다. 택사 추출물의 항산화 효과 측정을 위하여 삼각플라스크에 리놀레산(linoleic acid) 1g, 에탄올(ethanol) 10ml 및 소정의 택사 추출물을 첨가한 후 0.2M 인산완충용액(phosphate buffer) 25ml를 가하여 37℃에서 일정기간 저장한 다음 반응용액을 분액깔대기에 옮겨 클로로포름(chloroform) 25ml를 가하여 2∼3회 반복 추출하였다. 상기 클로로포름(chloroform) 추출액에 아세트산(acetic acid) 25ml와 포화 KI용액 1ml를 가하여 암소에서 5분간 방치한 다음 증류수 50ml를 가하여 1/100 N Na2S2O3용액으로 적정하였다. 택사추출물은 각각 메탄올, 에탄올, 물추출물을 첨가하였고, BHT 0.1%를 첨가하여 50℃에서 7일간 저장하면서 과산화물가를 측정하였다.The in vitro antioxidant and hepatic lipid peroxidation inhibitory effects on linoleic acid of Alismatis Rhizoma were investigated. In order to measure the antioxidant effect of taxa extract, 1 g of linoleic acid, 10 ml of ethanol, and a predetermined taxa extract were added to a Erlenmeyer flask, and 25 ml of 0.2 M phosphate buffer was added and stored at 37 ° C. for a period of time. Then, the reaction solution was transferred to a separatory funnel, and 25 ml of chloroform was added thereto, followed by extraction two to three times. 25 ml of acetic acid and 1 ml of saturated KI solution were added to the chloroform extract, which was allowed to stand in the dark for 5 minutes, and then 50 ml of distilled water was added and titrated with a 1/100 N Na 2 S 2 O 3 solution. Taxi extract was added methanol, ethanol, and water extract, respectively, and BHT 0.1% was added and stored at 50 ° C. for 7 days to measure peroxide value.

택사 추출물의 지질과산화 억제효과는 흰쥐의 간 균질액(liver homogenate)를 사용하여in vitro로 조사하였다. 흰쥐의 간을 적출하여 인산완충용액(phospha-Lipid peroxidation inhibitory effect of Taxa extract was investigated in vitro using liver homogenate in rats. Phosphate buffer solution (phospha-

te buffer, pH 7.4)로 균질화한 다음 균질액에 과산화수소(H2O2) 1M과 50mM의 황산철(FeSO4) 및 택사 추출물 0.05ml를 가하여 42℃에서 72시간 동안 저장한 후 생성된 TBARS(thiobarbituric acid reactive substances)함량을 측정하였다.After homogenization with te buffer, pH 7.4), 1M of hydrogen peroxide (H 2 O 2 ), 50 mM iron sulfate (FeSO 4 ), and 0.05 ml of taxa extract were added to the homogenate, and stored at 42 ° C. for 72 hours. thiobarbituric acid reactive substances) was measured.

실험결과, 도 4에 나타낸 바와 같이 택사 메탄올 추출물, 에탄올 추출물 및 물추출물 100㎕ 첨가시 대조구에 비하여 과산화가가 모두 낮게 나타났으며, 물추출물의 과산화물가는 메탄올 및 에탄올 추출물보다 작았으나, 0.1% BHT 첨가시 보다는 조금 높게 나타났다. 또한 택사 물추출물을 50, 100, 150 및 200㎕의 농도로 첨가한 후 과산화물가를 측정한 결과 도 5에 나타낸 바와 같이 모두 대조구에 비하여 매우 낮게 나타났으며, 150㎕ 첨가시는 5일 저장시까지 과산화물이 거의 생성되지 않았는데 이는 0.1% BHT 100㎕를 첨가한 경우와 비슷한 정도의 효과였다. 권 등(권오근, 손진창, 김상철, 정신교, 박승우 :한국농산물저장유통학회(1998), 5(281))은 목단피 메탄올 추출물의 에칠아세테이트 분획의 리놀레산(linoleic acid)에 대한 항산화 효과가 87.3%이었고, 비교구인 BHT는 96.2%로 나타났다고 보고하였고, 서 등(서권일, 이상원, 양기호 :한국농산물저장유통학회(1999), 6(1))은 리놀레산(linoleic acid)에 대하여 산수유 물추출물을 10, 30 및 50㎕ 첨가하고 50℃에서 7일간 저장한 후 과산화물가를 측정한 결과 대조구의 187meq/kg에 비하여 42, 30 및 25meq/kg으로 나타나 상당한 항산화 효과가 있는 것으로 보고하였는데, 본 실험결과 택사 물추출물을 50㎕만 첨가하여도 상당한 항산화 효과가 있는 것으로 나타났다.As a result, as shown in FIG. 4, when the methanol extract, ethanol extract and 100 μl of water extract were added, the peroxide value was lower than that of the control, and the peroxide value of the water extract was smaller than that of the methanol and ethanol extracts. A little higher than when added. In addition, as a result of measuring the peroxide value after adding the water extracts of the taxi water at the concentrations of 50, 100, 150 and 200 μl, as shown in FIG. 5, all of them were very low compared to the control, and when 150 μl was added, the peroxide until 5 days storage. This was hardly produced, which was about the same as adding 100 μl of 0.1% BHT. Kwon et al. (Kwon Oh-Geun, Son Jin-Chang, Sang-Chul Kim, Sang-Cheol Kim, Pyo-Sang, Park, Seung-Woo: Korean Society of Agricultural Products and Storage (1998), 5 (281)) showed that the antioxidant activity of linoleic acid in the ethyl acetate fraction of methanol extract was The comparison group reported that BHT was 96.2%, and Seo et al. (Seo, Kwon-Il, Sang-Won Lee, and Ki-Ho Yang: Korean Agricultural Products Storage and Distribution Association (1999), 6 (1)) showed that the extracts of linusic acid were 10, 30 and After adding 50 μl and storing at 50 ° C. for 7 days, the peroxide value was measured to be 42, 30 and 25 meq / kg compared to 187 meq / kg of the control, which showed a significant antioxidant effect. Addition of only μl showed significant antioxidant effect.

흰쥐의 간 지질에 대한 TBA가는 도 6에 나타낸 바와같이 택사 물추출물울 첨가하지 않은 대조구에서 3597μmol malondialdehyde(MDA)/g liver이었고, 택사 물추출물을 첨가한 시험구들의 TBA가는 1443 μmol MDA/g liver로서 모두 대조구에 비하여 낮게 나타나 항산화 효과가 있었다.The TBA value of liver lipids in rats was 3597 μmol malondialdehyde (MDA) / g liver in the control group without the addition of taxa water extract as shown in FIG. 6, and the TBA value of the test groups to which the taxa water extract was added was 1443 μmol MDA / g liver. All showed lower anti-oxidant effect than the control.

실험예 3: 택사 추출물의 면역활성 측정Experimental Example 3: Determination of Immune Activity of Taxa Extract

택사(Alismatis Rhizoma) 추출물의 면역세포 증식효과, 대식세포주의 일산화질소 생산에 미치는 영향, 동종항원에 대한 증식반응, 동종항원에 의한 T세포 사이토카인(cytokine) 분비량의 억제, 동종항원에 대한 T세포의 살세포 작용 억제효과 등을 조사하였다. 생쥐의 비장세포 분리를 위하여 생쥐(BALB/c)를 경추탈골로 희생시킨 후, 알콜로 소독하여 해부대에 올려놓고 오른쪽 옆구리쪽을 절개하여 비장을 떼어 내었다. 상기 비장을 핀셋을 이용하여 단일세포(single cell)로 만들고 세척용 배지로 3회 세척후 적당량의 10% FCS-RPMI 1640 배지에 희석하여 사용한다. 상기 분리된 비장세포를 10ml의 10% FCS-RPMI 1640에 희석한 후 40㎕ anti-Thy1.2 ascites를 넣고 4℃에서 60분간 배양하였다. 그 후에 4℃, 1200rpm에서 6분간 원심침전하여 5ml의 FCS-RPMI 1640에 희석하고 250㎕ rabbit complement를 첨가하여 37℃ 수욕에서 45분간 배양하였다. 그 다음 10ml 세척용 배지로 4℃, 1200 rpm에서 6분간 원심침전을 두 번 반복하고 10% FCS-RPMI 1640 배지 500㎕에 희석하여 세파독스 G-10(Sephadox G-10) 컬럼을 통과시켜서 B세포만을 순수분리 하였다. T세포의 분리는 상기 분리된 비장세포를 10% FCS-RPMI 1640 1ml에 희석하여 Nylon wool 컬럼에 넣고 37℃, 5% CO2 배양기에 60분간 배양하였다. 배양후 나일론 울(Nylon wool) 컬럼을 37℃로 미리 데워진 배지로 세척하여 비부착성인 T세포만을 순수 분리하여 alloreative T세포로 사용하였다.Effects of Alismatis Rhizoma Extract on the Proliferation of Immune Cells, Effects of Macrophage Cells on Nitric Oxide Production, Proliferative Response to Homologous Antigens, Inhibition of T Cell Cytokine Secretion by Homologous Antigens, and T Cells Against Homogenous Antigens The inhibitory effect of killer cells was investigated. To separate the splenocytes of the mice, the mice (BALB / c) were sacrificed with cervical distal bone, sterilized with alcohol, placed on the dissection, and the spleen was removed by dissecting the right flank. The spleen is made into single cells using tweezers, washed three times with washing medium, and diluted in an appropriate amount of 10% FCS-RPMI 1640 medium. The isolated splenocytes were diluted in 10 ml of 10% FCS-RPMI 1640, and 40 µl anti-Thy1.2 ascites were added thereto and incubated at 4 ° C. for 60 minutes. Thereafter, the mixture was centrifuged at 4 ° C and 1200rpm for 6 minutes, diluted in 5ml of FCS-RPMI 1640, and incubated for 45 minutes in a 37 ° C water bath by adding 250µl rabbit complement. Then, centrifugation was repeated twice for 6 minutes at 4 ° C. and 1200 rpm with 10 ml washing medium, diluted in 500 μl of 10% FCS-RPMI 1640 medium, and passed through a Sephadox G-10 column. Only cells were purified. Separation of T cells was diluted in 1 ml of 10% FCS-RPMI 1640 and the splenocytes were separated into nylon wool column and incubated for 60 minutes in 37 ℃, 5% CO2 incubator. After incubation, the nylon wool column was washed with media preheated to 37 ° C., and only non-adherent T cells were purified and used as alloreative T cells.

비장세포, 순수 분리한 B세포, 또는 순수 분리한 T세포에 allogenic 비장세포(C57BL/6)을 96 well plate에 넣고 여기에 택사 추출물을 1, 10, 100, 1000㎍/ml농도로 넣어 배양한 다음 2일, 3일 4일째에 각 세포의 증식정도를 측정하였다. 측정은 Cell titer96Aqueous One Solution Cell proliferation Assay(promega)를 사용하여 2일, 3일, 4일째 각각 배양된 배양액 100㎕에 세포역가측정용 시약(Cell titer) 15㎕씩 첨가하고 4∼8시간 동안 배양한 다음 490nm에서 O.D값을 측정하였다.Splenocytes, purely isolated B cells, or purely isolated T cells were cultured in 96 well plates with allogenic splenocytes (C57BL / 6) in 1, 10, 100, 1000 ㎍ / ml concentrations. Next, the proliferation of each cell was measured on day 2 and day 3 and day 4. Measure the cell titer96 15 μl of cell titer was added to 100 μl of the culture solution on day 2, 3, and 4 using Aqueous One Solution Cell proliferation Assay (promega), followed by incubation for 4 to 8 hours, followed by 490 nm. OD value was measured at.

택사 추출물이 대식세포주의 일산화질소 생산에 미치는 효과를 알아보기 위하여 택사 추출물을 1, 10, 100, 1000㎍/㎖의 농도로 단독 처리하거나 또는 LPS, IFN-γ를 같이 첨가하였을 때, 대식세포가 생산하는 일산화질소의 농도를 측정하였다. 안정된 일산화질소(NO) 산화물인 NO2 -(nitrite)는 Griess 반응을 이용하여 측정하였다. 대식세포주(RAW264.7)를 적당한 조건하에서 48시간 배양한 후 배양 상층액을 96well plate에 100㎕씩 넣고 여기에 Greiss시약 (0.1%N-1-naphthyl-ethylendiamine in H2O + 1% sulfanilamide in 5% H3PO4)을 동량 첨가하여 10분간 반응시킨 후, 마이크로플래이트 리더(microplate reader, TitertekMultiscan Plus, Finland)로 570nm에서 흡광도를 측정하였다. 질산염(Nitrate)의 농도는 질산 나트륨(sodium nitrite)을 32μM에서부터 0.25μM까지 2배씩 희석하여 얻은 표준 곡선과 비교하여 계산하였다.To investigate the effects of taxa extract on nitric oxide production in macrophages, macrophages were treated with 1, 10, 100, and 1000 µg / ml concentrations, or when LPS and IFN-γ were added. The concentration of nitric oxide produced was measured. Stable nitrogen monoxide (NO) oxide, NO 2 - (nitrite) was measured using the Griess reaction. Incubate the macrophage line (RAW264.7) under appropriate conditions for 48 hours, add 100 µl of the culture supernatant to a 96well plate, and add Greiss reagent (0.1% N -naphthyl-ethylendiamine in H 2 O + 1% sulfanilamide in After reacting for 10 minutes by adding the same amount of 5% H 3 PO 4 ), the absorbance was measured at 570 nm with a microplate reader (Titertek Multiscan Plus, Finland). The concentration of nitrate was calculated by comparison with a standard curve obtained by diluting sodium nitrite from 32 μM to 0.25 μM in 2-fold.

택사 추출물이 동종항원에 의한 증식반응에 어떠한 효과를 나타내는지 알아보기 위하여, 동종항원을 유도하기 위한 세포수 결정실험을 수행하였다.표적세포(Target cells)인 MMC를 처리한 생쥐 C57BL/6의 비장세포와 효과세포(Effector cells)로 비장세포에서 분리한 T세포(생쥐 BABL/c의 T세포)를 함께 3일동안 배양하여 최대 증식반응을 나타내는 조건을 확인하였다.To determine the effect of taxa extract on the proliferative response by homologous antigens, a cell number determination experiment was conducted to induce homologous antigens. Spleen of mouse C57BL / 6 treated with target cells, MMC Cells and effector cells (Effector cells) T cells isolated from splenocytes (T cells of mouse BABL / c) were cultured together for 3 days to confirm the conditions showing the maximum proliferative response.

동종항원에 의한 T세포의 증식반응이 택사 추출물에 의하여 유의하게 억제된 원인을 알아보기 위하여, 동종항원에 반응하는 T세포가 분비하는 사이토카인(cytokine)의 생산량을 측정하였다. T세포가 반응할 때 분비하는 사이토카인(cytokine)의 양은 비장세포와 택사를 같이 배양한 상층액을 24시간 후에 회수하여 상층액에 포함된 IL-2, IL-4, IFN-γ,IL-10의 양을 ELISA(enzyme linked immounso-In order to determine the cause of the proliferation of T cells caused by allogeneic antigens significantly inhibited by the taxa extract, the amount of cytokines produced by T cells in response to allogeneic antigens was measured. The amount of cytokines secreted when T cells reacted was recovered after 24 hours of supernatant cultured with splenocytes and taxa, and IL-2, IL-4, IFN-γ, IL- contained in the supernatant. The amount of 10 ELISA (enzyme linked immounso-

rbent assay)kit로 측정하였다. 이때 사이토카인(cytokine) 농도의 측정 한계치는 10pg/ml이었다.It was measured by an rbent assay kit. At this time, the limit of measurement of cytokine concentration was 10 pg / ml.

비장세포 분리방법을 이용하여 C57BL/c 생쥐로부터 비장세포를 분리하여 마지막에 2ml의 10% FCS-RPMI 배지에 희석하고 200㎕의 마이토마이신 C(mytomycin C) 2mg/ml를 첨가하여 37℃ 수욕(water bath)에 25분간 처리하였다. 그 다음 세척용 배지로 4℃, 1200rpm에서 6분간 원심침전을 다섯번 반복하여 세척한 다음 allogen-Splenocytes were isolated from C57BL / c mice using the splenocyte separation method, diluted in 2ml of 10% FCS-RPMI medium, and 200mg of mytomycin C was added to 2mg / ml. (water bath) was treated for 25 minutes. Then, wash repeatedly with centrifuged sedimentation for 5 minutes at 4 ℃ and 1200rpm for 5 minutes with washing medium.

ic 비장세포 또는 표적세포로 사용하였다.Used as ic splenocytes or target cells.

표적세포(Target cell, allogeneic spleen cells, 1×107, 5×106/well)와 효과세포(Effetor cell,T cells, 1×106/well)의 비율(ratio)을 10:1 또는 5:1로 하여 둥근바닥 96well plate에 최종부피가 100㎕되도록 넣고 4℃, 250g에서 5분간 원심침전 시킨 후 37℃, 5% CO2배양기에 8시간 배양하였다. 단, 배양시간이 8시간이 되기 45분전에 Target maximum과 부피보정 대조구(Volume correcting control)에는 용해완충용액(Lysis Buffer)를 10배 희석하여 첨가하여 세포의 용해도가 최대가 되도록 하였다. 배양 후 4℃, 250g에서 5분간 원심침전 시킨 다음 상층액 50㎕를 떠서 평평한 바닥의 96well plate에 옮기고 여기에 50㎕ 기질혼합 완충용액(substrate mix Buffer)를 첨가하고 실온에서 알루미늄 호일을 덮어 30분간 반응시킨 다음 50㎕ 정지용액(stop soultion)을 넣고 마이크로플래이트 리더(microplate reader)를 이용하여 490nm에서 O.D.를 측정하고 상층액내에 있는 락테이트 디하이드로게나아제(lactate dehydrogenase, LDH)의 양을 측정하여 살세포작용 정도를 나타내었다. 살세포작용 정도는 하기의 식을 이용하여 산출하였다.The ratio of target cells (allogeneic spleen cells, 1 × 10 7 , 5 × 10 6 / well) and effector cells (Effetor cell, T cells, 1 × 10 6 / well) is 10: 1 or 5 : into a final volume of 96well round bottom plate 1 so as to 100㎕ were incubated 8 hours for 4 ℃, then centrifuged 5 minutes in the precipitation 250g 37 ℃, 5% CO 2 incubator. However, 45 minutes before the incubation time was 8 hours, the target maximum and volume correcting control (Lysis Buffer) was diluted 10-fold and added to the cell solubility to the maximum. After incubation, centrifuged for 5 minutes at 250 g at 4 ° C. Then, 50 µl of the supernatant was transferred to a 96-well plate on a flat bottom, and 50 µl substrate mix buffer was added thereto, and the aluminum foil was covered at room temperature for 30 minutes. After the reaction, 50 μl stop soultion was added and the OD was measured at 490 nm using a microplate reader. The amount of lactate dehydrogenase (LDH) in the supernatant was measured. The degree of killer cell activity was shown. The degree of killer cell activity was calculated using the following equation.

% CYTOTOXICITY=% CYTOTOXICITY = Expermental-Effector Spontaneous-Target SpontaneousExpermental-Effector Spontaneous-Target Spontaneous ×100× 100 Target Maximum-Target SpontaneousTarget Maximum-Target Spontaneous

생쥐의 비장세포에 택사 추출물을 농도별로 처리하여 세포의 증식정도를 측정한 결과 도 7a에 나타낸 바와 같이 무처리 대조군에 비해 택사 추출물을 처리한 실험군의 비장세포 증식정도가 농도 의존적으로 증가함을 알 수 있었다. 비장세포에 포함되어 있는 B세포만을 분리하여 택사의 B세포증식 유도효과를 측정한 결과, 도 7b에 나타낸바와 같이 비장세포에서와 마찬가지로 농도 의존적으로 증식을 증가시켰으며 특히 1000㎍/㎕의 농도에서는 월등한 상승효과가 있음을 알 수 있었다.As a result of measuring the proliferation of cells by the concentration of taxa extract to the splenocytes of the mouse by concentration, as shown in FIG. 7a, the concentration of the spleen cells of the experimental group treated with the extract was increased in a concentration-dependent manner as shown in FIG. 7A. Could. As a result of measuring B cell proliferation induction effect of taxa by separating only B cells contained in splenocytes, as shown in FIG. 7B, proliferation was increased in a concentration-dependent manner as in splenocytes, especially at a concentration of 1000 ㎍ / μl. It was found that there was an excellent synergistic effect.

택사 추출물이 대식세포주의 일산화질소(NO) 생산에 미치는 효과를 조사한결과, 표 2에 나타낸바와 같이 무처리 대조군과 비교해보면 택사 추출물을 농도별로 단독 처리한 실험군과 LPS를 1㎍/㎖을 같이 처리한 실험군에서는 모두 대식세포의 일산화탄소(NO) 생산이 유도되지 않았다. 그러나 1ng/㎖의 IFN-γ를 같이 처리한 실험군에서는 택사 추출물의 농도가 낮을때는 약간 감소하는 경향을 보였지만, 고농도에서 일산화질소(NO)생산이 유의있게 증가하는 것을 알 수 있었다. 즉, 택사추출물이 1000㎍/㎕같은 고농도에서는 IFN-γ에 의해 유도되는 일산화질소(NO) 생산에 상승적 작용을 하는 것을 알 수 있었다.As a result of investigating the effect of taxa extract on nitric oxide (NO) production of macrophage, as compared with the untreated control group, as shown in Table 2, the experimental group treated with taxa extract by concentration alone and LPS were treated together with LPS. None of the experimental groups induced carbon monoxide (NO) production in macrophages. However, the experimental group treated with 1ng / ml of IFN-γ showed a tendency to decrease slightly at low concentrations of the taxa extract, but it was found that the production of nitric oxide (NO) was significantly increased at high concentrations. In other words, it can be seen that the taxa extract has a synergistic effect on the production of nitrogen monoxide (NO) induced by IFN-γ at high concentrations such as 1000 µg / µl.

택사 추출물이 대식세포주 RAW 264.7의 일산화질소 생산에 미치는 영향Effects of Taxa Extracts on Nitric Oxide Production in Macrophage Cell RAW 264.7 택사 추출물Taxa Extract 자 극 제Stimulant 00 LPS(1㎍/㎖)LPS (1 μg / ml) IFN-γ(1ng/㎖)IFN-γ (1 ng / ml) 00 4.17±1.574.17 ± 1.57 3.81±1.253.81 ± 1.25 5.47±1.745.47 ± 1.74 1One 2.90±0.132.90 ± 0.13 3.12±0.083.12 ± 0.08 2.86±0.232.86 ± 0.23 1010 2.87±0.242.87 ± 0.24 2.66±0.192.66 ± 0.19 3.50±0.203.50 ± 0.20 100100 3.02±0.103.02 ± 0.10 3.02±0.713.02 ± 0.71 6.43±0.016.43 ± 0.01 10001000 4.49±1.474.49 ± 1.47 5.87±2.625.87 ± 2.62 21.44±3.0421.44 ± 3.04 〔주〕택사 추출물 단위: ㎍/㎖Taxa extract unit: µg / ml

택사 추출물이 동종항원에 의한 증식반응에 미치는 효과를 조사한 결과, 도 8a에 나타낸 바와 같이 동일한 표적세포의 수(5×105cells/well)일 때 효과세포의 수가 well당 1×106cells이 배양 후 3일째에 최대 증식반응을 나타내었다. 따라서, 동일한 조건에서 0.01, 0.1, 1, 10㎍/㎖의 택사 추출물을 같이 처리하여 배양 후 3일째 증식반응을 측정한 결과, 도 8b에 나타낸 바와 같이 택사 추출물의 농도 의존적으로 동종항원에 대한 증식반응이 억제되는 것을 알 수 있었다. 즉, 1㎍/㎖에서 최대 약 50%정도의 증식 억제효과를 나타내었다.Alismataceae extract a number of 1 × 10 6 cells per well of the results of the investigation of the effect on the proliferation induced by alloantigen, effective cell when the same number of target cells (5 × 10 5 cells / well ) as shown in Figure 8a is Maximum proliferative response was seen at 3 days after culture. Therefore, as a result of measuring the proliferative response on day 3 after culturing by treating 0.01, 0.1, 1, 10 μg / ml taxa extract under the same conditions, as shown in FIG. It was found that the reaction was suppressed. In other words, the maximum inhibitory effect of about 50% at 1 ㎍ / ㎖.

T세포가 생산하는 사이토카인(cytokine)의 생산량을 측정한 결과, 표 3에 나타낸 바와 같이 동종항원에 대해 반응하는 T세포는 IL-2, IL-10 및 IFN-γ 등을 생산하였지만, 택사 추출물을 첨가한 실험군에서 IL-2, IFN-γ 및 IL-10의 생산량이 억제됨을 알 수 있었다. 따라서, 택사 추출물은 동종항원에 대해 반응하는 T세포의 사이토카인(cytokine) 생산을 억제함으로써 분열 증식을 저해하는 것으로 생각된다.As a result of measuring the amount of cytokines produced by T cells, T cells responding to homologous antigens produced IL-2, IL-10 and IFN-γ, as shown in Table 3. It was found that the production of IL-2, IFN-γ and IL-10 was suppressed in the experimental group added. Therefore, it is thought that the taxa extract inhibits cleavage proliferation by inhibiting cytokine production of T cells in response to homologous antigens.

택사 추출물이 동종항원에 대해 반응하는 T세포의 사이토카인 분비에 미치는 영향Effects of Taxa Extracts on Cytokine Secretion of T Cells Responding to Homologous Antigens 실험 조건Experimental conditions 사이토카인(cytokines)Cytokines IL-2IL-2 IFN-γIFN-γ IL-4IL-4 IL-10IL-10 T 세포T cell <10<10 94.3±17.294.3 ± 17.2 <10<10 200.0±21.2200.0 ± 21.2 T 세포+ 비장T cell + spleen 372.4±4.2372.4 ± 4.2 644.3±12.1644.3 ± 12.1 104±13.3104 ± 13.3 430.0±148.5430.0 ± 148.5 T 세포+비장+택사 추출물T Cell + Spleen + Taxa Extract 316.4±3.7316.4 ± 3.7 422.9±23.2422.9 ± 23.2 <10<10 205.0±70.7205.0 ± 70.7 〔주〕사이토카인 단위: pg/㎖(Note) Cytokine Unit: pg / ml

택사 추출물이 동종항원에 대한 T세포의 살세포작용에 미치는 영향을 조사한 결과, 도 9에 나타낸바와 같이 동종항원에 대한 T세포의 살세포 작용을 택사 추출물이 저농도인 1㎍/㎖에서 완전히 억제함을 알 수 있었다. 따라서, 택사 추출물은 동종항원에 대한 T세포의 사이토카인(cytokine) 생산량을 억제함으로써 분열증식을 억제하였고, T세포의 동종항원에 대한 살세포 작용도 억제하는 것으로 나타났다.As a result of investigating the effect of Taxi extract on T cell apoptosis on allogeneic antigen, as shown in FIG. 9, the Taxi extract completely inhibited T-cell apoptosis on homologous antigen at low concentration of 1㎍ / ml And it was found. Therefore, the extract of Taeksa inhibited the proliferation by inhibiting the cytokine production of T cells against homologous antigens, and also inhibited the killer cell activity against homologous antigens of T cells.

실시예 1: 택사 과립차 제조Example 1 Preparation of Taxa Granule Tea

제 1공정: 택사 엑기스 제조First step: manufacturing tax extract

택사의 고유한 맛을 보전시키기 위하여, 택사에 70% 에탄올을 첨가하여 80℃에서 3회에 걸쳐 5시간 추출하였다. 상기 추출과정에서 택사에 첨가하는 에탄올의 양은 1회 추출시에는 택사 부피의 9배, 2회 추출시에는 5배, 3회 추출시에는 5배를 각각 가하여 추출하였다. 상기 추출액을 와트만 41(Whatman 41) 여과지를 사용하여 여과한 다음 농축하여 엑기스를 제조하였다. 이때 엑기스 고형분의 수율은 28.17% 였으며 수분함량은 42.3%였고 Bx53 이었다.To preserve the intrinsic taste of the taxi, 70% ethanol was added to the taxi and extracted three times at 80 ° C. for 5 hours. In the extraction process, the amount of ethanol added to the taxi was extracted by adding 9 times the volume of the taxi at the time of extraction, 5 times at the time of extraction, and 5 times at the time of extraction. The extract was filtered using Whatman 41 filter paper and then concentrated to prepare an extract. The yield of extract solids was 28.17%, moisture content was 42.3% and Bx53.

제 2공정: 부재료의 칭량 ,분쇄 및 혼합Second Step: Weighing, Grinding and Mixing of Substances

택사 과립차 제조시 부재료로 쓰이는 유당, 포도당 및 비타민 C(Vit C)를 각각 전체 과립차 함량의 30.60%, 56.71%, 0.71% 되도록 칭량한 후 혼합하고 분쇄한 뒤 80 mesh 크기로 사별하였다.Lactose, glucose, and vitamin C (Vit C), which are used as subsidiary materials in the preparation of taxi granule tea, were weighed to 30.60%, 56.71%, and 0.71% of the total granular tea content, respectively, mixed, ground, and separated into 80 mesh sizes.

제 3공정: 택사 엑기스와 부재료의 혼합 및 제립Third Step: Mixing and Granulating Taxi Extract and Substances

상기 제 1공정과 제 2공정에서 제조한 택사 엑기스와 부재료인 유당, 포도당, 비타민C를 표 4에 나타낸 바와같은 비율로 혼합한 뒤 역회전 과립기로 과립을 성형하였다.After mixing the taxi extract prepared in the first step and the second step and lactose, glucose, vitamin C which is a subsidiary ingredient in the ratio as shown in Table 4, the granules were molded by a reverse rotation granulator.

택사 과립차의 배합성분 및 함량Ingredients and Contents of Taxi Granulated Tea 배합 성분Compounding ingredient 함 량content 비 고Remarks 택사 추출물Taxa Extract 11.9811.98 70% 알콜엑기스70% alcohol extract 유 당Lactose 30.6030.60 포도당glucose 56.7156.71 비타민 CVitamin c 0.710.71 system 100.00100.00 〔주〕단위 : %(Note) Unit:%

제 4공정 : 택사 추출물 과립의 건조, 사별 및 포장Fourth Step: Drying, Sifting and Packing of Taxa Extract Granules

상기 제 3공정에서 제조된 택사 추출물 과립을 수분이 5% 이하가 되도록 60℃에서 5시간동안 건조시킨 후 15∼20mesh 크기로 사별하였다. 상기 택사과립차는 3.0g/포 단위로 열접착한 Al foil Tea bag 에 포장하였다.The tack extract extract granules prepared in the third step were dried at 60 ° C. for 5 hours so that the water content was 5% or less, and then separated into 15-20 mesh sizes. The granulated granule tea was packed in an Al foil Tea bag heat-bonded by 3.0g / sachet.

이상, 상기 실시예를 통하여 설명한 바와 같이 본 발명의 택사 추출물은 항균활성, 항산화효과 및 면역활성이 뛰어나며, 택사추출물을 부재료와 함께 혼합하여 택사과립차로 제조함으로서 택사의 고유한 조맛과 단맛이 조화를 이루는 음용이 간편한 택사과립차를 제공하는 효과가 있으므로 식품가공학적 측면에서 매우 유용한 발명인 것이다.As described above, the tax extract of the present invention has excellent antimicrobial activity, antioxidant effect, and immune activity, and is mixed with subsidiary materials to produce taxa granule tea, and thus, the unique taste and sweetness of taxa are harmonized. It is a very useful invention in terms of food processing because it has the effect of providing a convenient tack granule tea drinking.

Claims (2)

(a) 택사에 70%에탄올을 가하여 80℃에서 3 내지 7시간 동안 추출하여 택사 알콜엑기스를 제조하는 단계;(a) adding 70% ethanol to the taxi and extracting at 80 ° C. for 3 to 7 hours to prepare a taxi alcohol extract; (b) 부원료로 첨가되는 유당, 포도당 및 비타민C를 각각 전체 과립차 함량의 20 내지 40%, 50 내지 60%, 1 내지 10%되도록 칭량하고 혼합하여 분쇄하는 단계;(b) weighing, mixing and grinding lactose, glucose and vitamin C added as an auxiliary material to 20-40%, 50-60%, 1-10% of the total granular tea content, respectively; (c) 상기 (b)단계의 부원료에 상기 (a)단계의 택사 알콜 엑기스를 첨가하고 혼합한 뒤 역회전 과립기를 사용하여 제립하는 단계;(c) adding and mixing the taxi alcohol extract of step (a) to the subsidiary material of step (b) and granulating using a reverse rotating granulator; (d) 상기 (c)단계에서 제조한 택사 추출물 과립을 50 내지 70℃에서 3 내지 7시간 동안 건조한 후 포장하여 제품화하는 단계를 포함하는 것을 특징으로 하는 택사과립차 제조방법.(D) a method for preparing a coarse granule tea comprising the step of packaging the tack extract extract granules prepared in step (c) at 50 to 70 ℃ for 3 to 7 hours and then packaging the product. 제 1항의 방법으로 제조된 택사과립차.A granulated granular tea prepared by the method of claim 1.
KR10-2000-0078054A 2000-12-18 2000-12-18 Alismatis Rhizoma tea of granule type and process for prepatration therof KR100392277B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0078054A KR100392277B1 (en) 2000-12-18 2000-12-18 Alismatis Rhizoma tea of granule type and process for prepatration therof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0078054A KR100392277B1 (en) 2000-12-18 2000-12-18 Alismatis Rhizoma tea of granule type and process for prepatration therof

Publications (2)

Publication Number Publication Date
KR20020048781A KR20020048781A (en) 2002-06-24
KR100392277B1 true KR100392277B1 (en) 2003-07-22

Family

ID=27682984

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0078054A KR100392277B1 (en) 2000-12-18 2000-12-18 Alismatis Rhizoma tea of granule type and process for prepatration therof

Country Status (1)

Country Link
KR (1) KR100392277B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102908409A (en) * 2012-11-15 2013-02-06 成都乾坤动物药业有限公司 Production process of Chinese rhubarb fine powder granules
CN115350197B (en) * 2022-07-05 2023-06-13 华南农业大学 Application of alisol A-24-acetate in improving sensitivity of MRSA to beta-lactam antibiotics

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930019113A (en) * 1992-03-02 1993-10-18 박정윤 Cornus powder tea prepared from Cornus extract and its manufacturing method
KR19980057244A (en) * 1996-12-30 1998-09-25 백운화 Tea composition using herbal medicine and its manufacturing method
KR19980066045A (en) * 1997-01-18 1998-10-15 이영호 Pure X-dried powder of herbal medicine containing no excipients and preparation method thereof
KR20000049491A (en) * 2000-03-30 2000-08-05 이병두 Diet food having green tea and the method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930019113A (en) * 1992-03-02 1993-10-18 박정윤 Cornus powder tea prepared from Cornus extract and its manufacturing method
KR19980057244A (en) * 1996-12-30 1998-09-25 백운화 Tea composition using herbal medicine and its manufacturing method
KR19980066045A (en) * 1997-01-18 1998-10-15 이영호 Pure X-dried powder of herbal medicine containing no excipients and preparation method thereof
KR20000049491A (en) * 2000-03-30 2000-08-05 이병두 Diet food having green tea and the method

Also Published As

Publication number Publication date
KR20020048781A (en) 2002-06-24

Similar Documents

Publication Publication Date Title
Parmar et al. Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones
Martín‐Vertedor et al. Bioavailability of bioactive molecules from olive leaf extracts and its functional value
Amin et al. In-vitro antioxidant and antibacterial activities of pumpkin, quince, muskmelon and bottle gourd seeds
Mianabadi et al. Antimicrobial and Anti-oxidative Effects of Methanolic Extract of Dorema aucheri Boiss.
Kim et al. Isolation of abscisic acid from Korean acacia honey with anti-Helicobacter pylori activity
Chingwaru et al. Antibacterial and anticandidal activity of Tylosema esculentum (marama) extracts
Hudz et al. Analytical procedure elaboration of total flavonoid content determination and antimicrobial activity of bee bread extracts
Bae et al. Production of sesaminol and antioxidative activity of fermented sesame with Lactobacillus plantarum P8, Lactobacillus acidophilus ATCC 4356, Streptococcus thermophilus S10
Megateli et al. Enhancement of total phenolic and flavonoids extraction from Rosmarinus officinalis L using electromagnetic induction heating (EMIH) process
Ethiraj et al. Phytochemical and biological activity of Cucurbita seed extract
KR100392277B1 (en) Alismatis Rhizoma tea of granule type and process for prepatration therof
KR101692889B1 (en) Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases
Heirangkhongjam et al. Nutritional evaluation of Rhus chinensis Mill.(Heimang) and development of value added products
Beyazen et al. Phytochemical screening, antioxidant and antimicrobial activities of seeds of Foeniculum vulgare (ensilal)
Othman et al. Phenolic Content as Antioxidant and Antimicrobial Activities of Pistacia atlantica Desf.(Anacardiaceae) Extract from Libya
KR100440493B1 (en) Healthy drink comprising Alismatis Rhizoma extract and process for prepatration therof
KR101106056B1 (en) Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof
KR100392775B1 (en) Alismatis Rhizoma tea of rosted type and process for prepatration thereof
KR20190006285A (en) Antibacterial composition comprising an extract of schisandra chinesis
Liu et al. Preparation, characterization, identification, and antioxidant properties of fermented acaí (Euterpe oleracea)
KR101106055B1 (en) Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof
De Nkainsa et al. Phytochemical analysis and in vitro antimicrobial screenings of the methanolic stem bark extract and constituents of Parkia bicolor A. Chev.(Leguminosae)
KR20020048778A (en) Alismatis Rhizoma fermented wine and process for prepatration therof
Kamel et al. Antibacterial activity of Pistacia khinjul fatty acids extract on some pathogenic bacteria
Mezni et al. Effect of Growing Area on Total Polyphenols, Flavonoids, Tannins and Antimicrobial Activity in Quercus Suber l. Acorn Oil

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130805

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20140703

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20150626

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20160518

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20170628

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20190701

Year of fee payment: 17